Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,290 | 325 | 98.3% |
| Education | $92.89 | 8 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $653.73 | 42 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $618.10 | 47 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $501.97 | 27 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $499.97 | 32 | $0 (2020) |
| Astellas Pharma US Inc | $388.14 | 19 | $0 (2019) |
| Novo Nordisk Inc | $335.22 | 24 | $0 (2019) |
| PFIZER INC. | $276.15 | 22 | $0 (2019) |
| Lilly USA, LLC | $224.83 | 14 | $0 (2019) |
| Amgen Inc. | $195.82 | 11 | $0 (2020) |
| SANOFI PASTEUR INC. | $190.56 | 11 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $40.57 | 2 | Sumitomo Pharma America, Inc. ($23.34) |
| 2022 | $171.54 | 4 | E.R. Squibb & Sons, L.L.C. ($90.32) |
| 2021 | $26.92 | 2 | AbbVie Inc. ($26.92) |
| 2020 | $191.17 | 11 | Amgen Inc. ($41.86) |
| 2019 | $1,478 | 96 | AstraZeneca Pharmaceuticals LP ($213.95) |
| 2018 | $1,781 | 108 | AstraZeneca Pharmaceuticals LP ($302.87) |
| 2017 | $1,693 | 110 | Merck Sharp & Dohme Corporation ($220.16) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/03/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: UROLOGY | ||||||
| 12/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $90.32 | General |
| Category: Cardiovascular | ||||||
| 09/29/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.09 | General |
| 06/01/2022 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: Immunology | ||||||
| 06/01/2022 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Immunology | ||||||
| 04/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiovascular | ||||||
| 03/03/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Endocrinology | ||||||
| 02/28/2020 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Vaccines | ||||||
| 02/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/07/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Neuroscience | ||||||
| 02/04/2020 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological), SOLIQUA 100/33 | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Endocrinology | ||||||
| 01/24/2020 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Bone Health | ||||||
| 01/10/2020 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/03/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: Cardiovascular | ||||||
| 12/17/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Endocrinology | ||||||
| 12/13/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 12/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: DIABETES | ||||||
| 11/26/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,660 | 4,389 | $852,583 | $211,065 |
| 2022 | 20 | 2,868 | 4,360 | $766,001 | $179,976 |
| 2021 | 17 | 2,922 | 4,152 | $832,050 | $205,438 |
| 2020 | 24 | 3,632 | 4,951 | $1.0M | $247,493 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 701 | 1,335 | $405,840 | $75,606 | 18.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 91 | 803 | $154,979 | $35,111 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $52,984 | $18,322 | 34.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 116 | 116 | $42,340 | $16,016 | 37.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 219 | 221 | $36,023 | $15,520 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 230 | 282 | $58,092 | $13,995 | 24.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $17,874 | $7,604 | 42.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 238 | 242 | $17,666 | $7,526 | 42.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 116 | 116 | $13,920 | $4,644 | 33.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 217 | 402 | $13,266 | $3,720 | 28.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 28 | 103 | $15,141 | $3,372 | 22.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 304 | 365 | $3,612 | $3,048 | 84.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $6,468 | $2,329 | 36.0% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 22 | 22 | $2,640 | $912.12 | 34.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 27 | 28 | $1,988 | $845.94 | 42.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,971 | $839.70 | 42.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $2,375 | $789.41 | 33.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 53 | 53 | $3,551 | $583.00 | 16.4% |
| 90471 | Administration of vaccine | Office | 2023 | 13 | 13 | $949.00 | $97.80 | 10.3% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 12 | 12 | $576.00 | $93.28 | 16.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 41 | $328.00 | $90.20 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 616 | 1,109 | $337,136 | $63,949 | 19.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 200 | 200 | $71,489 | $25,819 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 404 | 555 | $114,330 | $20,740 | 18.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 107 | 405 | $59,535 | $16,175 | 27.2% |
About Dr. Robert Pace, MD
Dr. Robert Pace, MD is a Family Medicine healthcare provider based in Waldorf, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326030040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Pace, MD has received a total of $5,382 in payments from pharmaceutical and medical device companies, with $40.57 received in 2023. These payments were reported across 333 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,290).
As a Medicare-enrolled provider, Pace has provided services to 12,082 Medicare beneficiaries, totaling 17,852 services with total Medicare billing of $843,972. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Waldorf, MD
- Active Since 08/18/2005
- Last Updated 04/10/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326030040
Products in Payments
- FARXIGA (Drug) $473.70
- JANUVIA (Drug) $353.96
- TOUJEO (Drug) $257.05
- MYRBETRIQ (Drug) $193.60
- JARDIANCE (Drug) $182.91
- ENTRESTO (Drug) $179.94
- STIOLTO RESPIMAT (Drug) $151.38
- ELIQUIS (Drug) $148.26
- Myrbetriq (Drug) $139.54
- PNEUMOVAX 23 (Biological) $139.46
- Victoza (Drug) $135.54
- Prolia (Biological) $127.69
- Trintellix (Drug) $126.80
- FLUZONE HIGH-DOSE (Drug) $116.10
- SPIRIVA RESPIMAT (Drug) $113.33
- CHANTIX (Drug) $112.15
- HUMALOG (Drug) $100.58
- XARELTO (Drug) $91.50
- Ozempic (Drug) $88.37
- PREVNAR - 13 (Biological) $81.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Waldorf
Dr. Karlene Ross, M.d, M.D
Family Medicine — Payments: $6,197
Dr. Georgia Cu, Md, MD
Family Medicine — Payments: $3,561
Nauras Hwig, Md, MD
Family Medicine — Payments: $1,506
Dainty Jackson, D. O, D. O
Family Medicine — Payments: $801.25
Stacy Ross, M.d, M.D
Family Medicine — Payments: $357.48
Eboni Martin, M.d, M.D
Family Medicine — Payments: $349.95